Porcine foetal and neonatal CYP3A liver expression

Main Article Content

Marie Louise Hiort Hermann
Mette Tingleff Skaanild *
(*) Corresponding Author:
Mette Tingleff Skaanild | mts@life.ku.dk

Abstract

Human cytochrome P450 3A7 (CYP3A7) and cytochrome P450 3A4 (CYP3A4) are hepatic metabolising enzymes which participates in the biotransformation of endo- and exogenous substances in foetuses and neonates respectively. These CYP3A enzymes display an inverse relationship: CYP3A7 is the dominant enzyme in the foetal liver, whereas the expression of CYP3A4 is low. After parturition there is a shift in the expression, thus CYP3A7 is down regulated, while the level of CYP3A4 gradually increases and becomes the dominant metabolising CYP3A enzyme in the adult. The minipig is increasingly being used as a model for humans in biomedical studies, because of its many similarities with the human physiology and anatomy. The aim of this study was to examine whether, as in humans, a shift is seen in the hepatic expression of a CYP3A7- like enzyme to cytochrome P450 3A29 (CYP3A29) (an orthologue to the human CYP3A4) in minipigs. This was elucidated by examining the hepatic mRNA expression of CYP3A7 and CYP3A29 in 39 foetuses and newborn Göttingen minipigs using quantitative real time polymerase chain reaction (qPCR). Furthermore the immunochemical level of CYP3A7-LE and CYP3A29 was measured in liver microsomes using western blotting. The expression of CYP3A29 was approximately 9- fold greater in neonates compared to foetuses, and a similar difference was reflected on the immunochemical level. It was not possible to detect a significant level of foetal CYP3A7 mRNA, but immunoblotting showed a visible difference depending on age. This study demonstrates an increase in the expression of CYP3A29, the CYP3A4 orthologue in perinatal minipigs as in humans, which suggests that the minipig could be a good model when testing for human foetal toxicity towards CYP3A4 substrates.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

Author Biographies

Marie Louise Hiort Hermann, Faculty of Life Sciences University of Copenhagen

Department of Veterinary Disease Biology

DMV

Mette Tingleff Skaanild, Faculty of Life Sciences University of Copenhagen

Department of Veterinay Disease Biology

Associate Professor

References

References
1 Bogaards JJ, Bertrand M, Jackson P, et al. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000;30:1131-52.

2 Svendsen O. The minipig in toxicology. Exp Toxicol Pathol 2006;57:335-9.

3 Meddahi A. Le miniporc comme modèle expérimental. Sci Tech Anim Lab 1994;19:11-27.

4 Bollen P, Ellegaard L. The Göttingen minipig in pharmacology and toxicology. Pharmacol Toxicol 1997;80:3-4.

5 Anzenbacher P, Soucek P, Anzenbacherova E, et al. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab Dispos 1998;26:56-9.
6 Skaanild MT, Friis C. Cytochrome P450 sex differences in minipigs and conventional pigs. Pharmacol Toxicol 1999;85:174-80.

7 Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
8 Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med 2005;352:2211-21.

9 Lacroix D, Sonnier M, Moncion A, et al. Expression of CYP3A in the human liver -- evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997;247:625-34.

10 Nelson DR. The cytochrome p450 homepage. Hum Genomics 2009;4:59-65.

11 Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 2002;3:561-97.

12 Bieche I, Narjoz C, Asselah T, et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007;17:731-42.

13 Komori M, Nishio K, Kitada M, et al. Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 1990;29:4430-3.

14 Yang HY, Lee QP, Rettie AE, Juchau MR. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis. Mol Pharmacol 1994;46:922-8.
15 Cresteil T. Onset of xenobiotic metabolism in children: toxicological implications. Food Addit Contam 1998;15 Suppl:45-51.

16 Nishimura M, Yaguti H, Yoshitsugu H, et al. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003;123:369-75.

17 Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999;39:1-17.

18 Shang H, Yang J, Liu Y, Wei H. Tissue distribution of CYP3A29 mRNA expression in Bama miniature pig by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Xenobiotica 2009;39:423-9.

19 Skaanild MT, Friss C. Characterization of the P450 system in Göttingen minipigs. Pharmacol Toxicol 1997;80 Suppl 2:28-33.

20 Anzenbacherova E, Baranova J, Zuber R, et al. Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1. Basic Clin Pharmacol Toxicol 2005;96:244-5.

21 Organisation for Economic Cooperation and Development (OECD): OECD guideline for the testing of chemicals. Proposal for updating guideline 414. Prenatal developmental toxicity study. Adopted 22nd January 2001. Available at: http://www.oecd.org/dataoecd/18/15/1948482.pdf

22 Schardein JL, Schwetz BA, Kenel MF. Species sensitivities and prediction of tetratogenic potential. Environ Health Perspect 1985;61:55-67.

23 Gillberg M, Skaanild MT, Friis C. Regulation of gender-dependent CYP2A expression in pigs: involvement of androgens and CAR. Basic Clin Pharmacol Toxicol 2006;98:480-7.

24 Leeder JS, Gaedigk R, Marcucci KA, et al. Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther 2005;314:626-35.

25 Nygard AB, Jorgensen CB, Cirera S, Fredholm M. Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol 2007;8:67.

26 U.S. National Library of Medicine. National Center for Biotechnology Information, NCBI. Available from: http://www.ncbi.nlm.nih.gov/ Accessed: October 2009.
27 Fox J. R Commander. Package ‘Rcmdr’ version 1.5-4. 2009. Available at: http://cs.swan.ac.uk/~csoliver/ok-sat-library/OKplatform/ExternalSources/sources/R/packages/Rcmdr.pdf

28 Marill J, Capron CC, Idres N, Chabot GG. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids. Biochem Pharmacol 2002;63:933-43.

29 Stevens JC, Hines RN, Gu C, et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 2003;307:573-82.

30 Schuetz JD, Beach DL, Guzelian PS. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994;4:11-20.